期刊文献+

胰腺癌术后肝转移的危险因素分析 被引量:7

Risk factors of liver metastasis in patients after radical resection of pancreatic cancer
原文传递
导出
摘要 目的分析影响胰腺癌术后肝转移的危险因素。方法回顾性分析2006年1月至2012年1月经手术切除原发灶、病理证实和完成随访的124例胰腺癌患者的临床病理资料。采用Logistic多因素分析影响胰腺癌术后肝转移的危险因素。结果124例胰腺癌根治术后发生肝转移48例(38.7%)。〈40岁、40~60岁、〉60岁患者的术后肝转移率分别为68.8%、33.3%和35.1%,身体质量指数(BMI)〈20kg/m^2、BMI20—25kg/m^2和BMI〉25kg/m^2患者的术后肝转移率分别为21.6%、44.1%和52.6%,发病确诊时间差≥3个月和〈3个月患者的术后肝转移率分别为59.4%和31.5%,术前合并和不合并脂肪肝患者的术后肝转移率分别为14.3%和43.7%,高分化、中分化、低分化患者的术后肝转移率分别为10.0%、35.4%和49.0%,脉管癌栓和无脉管癌栓患者的术后肝转移率分别为68.8%和34.3%,胰腺癌根治术后化疗和未行化疗患者的肝转移率分别为31.2%和51.1%,差异均有统计学意义(均P〈O.05)。单因素分析结果显示,年龄、BMI、发病确诊时间差、术前是否合并脂肪肝、组织学分级、浸润深度、脉管癌栓和术后化疗是影响胰腺癌术后肝转移的因素。Logistic多因素分析结果显示,BMI、发病确诊时间差、术前是否合并脂肪肝、组织学分级和脉管癌栓是影响胰腺癌术后肝转移的独立因素。结论术后胰腺癌患者的BMI、发病确诊时间差、组织学分级和脉管癌栓与肝转移有关。术前合并脂肪肝的胰腺癌患者术后不易发生肝转移。 Objective To analyze the risk factors of liver metastasis in patients after radical resection of pancreatic cancer. Methods One hundred and twenty-four patients with non-metastatic, resectable pancreatic cancer treated in our department between 2006 and 2012 were included in this study. All of these patients underwent resection of the primary tumor combined with extensive lymph node dissection. The development of postoperative liver metastases was carefully followed up, and the clinieopathological factors and molecular characteristics were evaluated by univariate analysis and multivariate logistic regression using SPSS 16.0 software. Results Forty-eight cases of liver metastases were found among the 124 cases of pancreatic cancer after radical surgery (38.7%). The rate of liver metastasis of pancreatic cancer after radical surgery in the age groups 〈40, 40-60, and 〉60 were 68.8%, 33.3% and 35.1%, respectively. The rate of liver metastasis in the body mass index (BMI) group 〈20 kg/m^2, 20-25 kg/m^2, and 〉25 kg/m^2 were 21.6%, 44. 1% and 52.6%, and the rate of liver metastasis in the time between the onset and diagnosis groups ≥ 3 months and 〈3 months were 59.4% and 31.5%, respectively. The rate of liver metastasis in patients with preoperative fatty liver was 14.3% and it was 43.7% in patients without preoperative fatty liver. The rate of liver metastasis in patients of histological high, medium and low grade was 10.0%, 35.4% and 49.0%, respectively. The rate of liver metastasis in patients with venous tumor thrombus was 68.8% and it was 34.3% in patients without venous tumor embolus. The rate of liver metastasis in patients with postoperative chemotherapy was 31.2% and it was 51.1% in patients without postoperative chemotherapy. All those differences had statistical significance (P〈0.05). Univariate analysis revealed that age, body mass index (BMI) , time between the onset and diagnosis, preoperative fatty liver, histological grading, tumor invasion depth, venous tumor embolus, and postoperative chemotherapy were significantly related to postoperative liver metastasis. Multivariate analysis revealed five statistically independent risk factors for postoperative liver metastasis: BMI, time between onset and diagnosis, preoperative fatty liver, histological grading, and venous tumor embolus. Conclusions Our data suggest that patient's BMI, time between onset and diagnosis, histological grade, and venous tumor embolus are significantly correlated with postoperative liver metastases in patients with pancreatic cancer. Pancreatic cancer patients with preoperative fatty liver have less postoperative liver metastasis.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2015年第4期312-316,共5页 Chinese Journal of Oncology
基金 国家自然科学基金(81272373)
关键词 胰腺肿瘤 肿瘤转移 危险因素 Pancreatic neoplasms Liver Neoplasm metastasis Risk factors
  • 相关文献

参考文献21

  • 1王丽,杨功焕,李辉,陆星华.1991-2000年中国胰腺癌病死率的变迁[J].中华内科杂志,2005,44(7):509-513. 被引量:39
  • 2Ouyang H, Wang P, Meng Z, et al. Multimodality treatment of pancreatic cancer with liver metastases using chemotherapy, radiation therapy, and/or Chinese herbal medicine]J]. Pancreas, 2011, 40( 1) : 120-125.
  • 3解亦斌,赵平,王成锋,单毅,赵东兵,刘骞,白晓枫.胰腺导管腺癌根治性切除术后复发转移及预后影响因素分析[J].中华肿瘤杂志,2008,30(9):686-689. 被引量:1
  • 4Paulson AS, Tran Cao HS, Tempero MA, et al. Therapeutic advances in pancreatic cancer[J]. Gastroenterology, 2013,144(6) :1316- 1326.
  • 5CommitteeofPancreaticCancer,ChineseAnti-cancerAssociation.Clinical Analysis of Pancreatic Cancer: A Report of 2340 Cases(2340例胰腺癌临床病例分析)[J].The Chinese-German Journal of Clinical Oncology,2003,2(2):76-81. 被引量:9
  • 6Levi Z, KarkJD, Afek A, et al. Measured body mass index in adolescence and the incidence of pancreatic cancer in a cohort of 720,000Jewish men[J]. Cancer Causes Control, 2012, 23 ( 2) : 371-378.
  • 7Bracci PM. Obesity and pancreatic cancer: overview of epidemiologic evidence and biologic mechanisms[J]. Mol Carcinog, 2012, 51 (1) :53-63.
  • 8Li D, MorrisJ5, LiuJ, et al. Body mass index and risk, age of onset, and survival in patients with pancreatic cancer] n.JAMA, 2009, 301 (24) : 2553-2562.
  • 9Fujioka 5, Misawa T, Okamoto T, et al. Predictors for postoperative liver metastasis in patients with resectable pancreatic cancer]J J. Int Surg , 2008, 93(6) :324-330.
  • 10Matsumoto G, Muta M, Tsuruta K, et al. Tumor size significantly correlates with postoperative liver metastases and COX-2 expression in patients with resectable pancreatic cancer[J]. Pancreatology, 2007, 7(2-3) : 167-173.

二级参考文献35

  • 1刘骞,赵平,王成峰,蔡建强,邵永孚,白晓枫.胰体尾癌外科治疗117例临床分析[J].中华外科杂志,2006,44(5):333-335. 被引量:24
  • 2Ozaki H, Hiraoka T, Mizumoto R, et al. The prognostic significance of lymph node metastasis and intrapancreatic perineural invasion in pancreatic cancer after curative resection. Surg Today, 1999, 29: 16-22.
  • 3Tsiotos GG, Famell MB, Sarr MG. Are the results of pancreatectomy for pancreatic cancer improving? World J Surg, 1999, 23:913- 919.
  • 4Han SS, Jang JY, Kim SW, et al. Analysis of long-term survivors after surgical resection for pancreatic cancer. Pancreas, 2006, 32 : 271-275.
  • 5Sperti C, Pasquali C, Piccoli A, et al. Recurrence after resection for ductal adenocarcinoma of the pancreas. World J Surg, 1997, 21:195-200.
  • 6Nagakawa T, Sanada H, Inagaki M, et al. Long-term survivors after resection of carcinoma of the head of the pancreas: significance of histologically curative resection. J Hepatobiliary Pancreat Surg, 2004, 11:402-408.
  • 7Winter JM, Cameron JL, Campbell KA, et al. 1423 pancreatieoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg, 2006, 10 : 1199-1211.
  • 8Takamori H, Hiraoka T, Kanemitsu K, et al. Identification of prognostic factors associated with early mortality after surgical resection for pancreatic cancer: under-analysis of cumulative survival curve. World J Surg, 2006, 30:213-218.
  • 9Schwarz RE, Smith DD. Extent of lymph node retrieval and pancreatic cancer survival: information from a large US population database. Ann Surg Oncol, 2006, 13 : 1189-1200.
  • 10Howard TJ, Krug JE, Yu J, et al. A margin-negative RO resection accomplished with minimal postoperative complications is the surgeon's contribution to long-term survival in pancreatic cancer. J Gastrointest Surg, 2006, 10 : 1338-1446.

共引文献47

同被引文献33

  • 1Cannistr/t M, Ruggiero M, Zullo A, et al. Metastases of pancreatic adenocarcinoma: A systematic review of literature and a new functional concept. Int 1 Sure, 2015, 6(26): 873-876.
  • 2Tafuto S, von Arx C, De Divitiis C, et al. Electrochemotherapy as a new approach on pancreatic cancer and on liver metastases. Int J Surg, 2015, 6(27): 382-385.
  • 3Ray K. Pancreatic cancer: Pancreatic cancer exosomes prime theliver for metastasis. Nat Rev Gastroenterol Hepatol, 2015, 12(7): 371-375.
  • 4Costa-Silva B, Aiello NM, Ocean AJ, et al. Pancreatic cancer exosornes initiate pre-metastatic niche formation in the liver. Nat CellBiol, 2015, 17(6): 816-826.
  • 5Peixoto RD, Speers C, McGahan CE, et al. Prognostic factors and sites of metastasis in unresectable locally advanced pancreatic cancer. CancerMed, 2015, 4(18): 1028-1033.
  • 6Han Y, Ru GQ, Mou X, et al. AUTS2 is a potential therapeutic target for pancreatic cancer patients with liver metastases. Med Hypotheses, 2015, 3(1): 920-923.
  • 7Nakayama A1, Tajima H, Kitagawa H, et al. A case report of hepatic arterial infusion chemotherapy and RFA for liver metastasis from pancreatic cancer. Gan To Kagaku Ryoho, 2014, 41(12): 2205-2207.
  • 8Kawamoto T, Hishima T, Kimura K, et al. Calcified liver metastases from a non-functioning pancreatic neuroendocrine tumor. Clin J Gastroenterol, 201, 7(5): 460-464.
  • 9Bolm L, lanssen S, Kismann L, et al. Predicting survival after irradiation of metastases from pancreatic cancer. Anticancer Res, 2015, 35(7): 4105-4108.
  • 10Cannistr~ M, Ruggiero M, Zullo A, et al. Metastases of pancreatic adenocarcinoma: a systematic review of literature and a new functional concept. Int J Surg, 2015, 6(26):873-876.

引证文献7

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部